HH-006
/ Huahui Health
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
April 07, 2023
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HH-006 in Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=33 | Completed | Sponsor: Huahui Health | Recruiting ➔ Completed
Trial completion • Hepatitis B • Hepatology • Infectious Disease • Inflammation
September 01, 2022
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HH-006 in Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=32 | Recruiting | Sponsor: Huahui Health | Not yet recruiting ➔ Recruiting
Enrollment open • Hepatitis B • Hepatology • Infectious Disease • Inflammation
March 11, 2022
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HH-006 in Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=32 | Not yet recruiting | Sponsor: Huahui Health
New P1 trial • Hepatitis B • Hepatology • Infectious Disease • Inflammation
1 to 3
Of
3
Go to page
1